Italian - ItalyEnglish (United Kingdom)

Life Science Accelerator

How: Business Model

CISI scrl is not a service company (non-profit nature), but neither is it an R & D company with an integrated structure within, as our platforms are almost exclusively oriented towards chemistry (see Platform Technologies). For this, our goal is to be considered an ideal partner for creating value on innovative projects in the field of Life Sciences, and consequently to work with public private research groups with competence and valuable assets in the pharmaceutical sector.

 

With what: Platforms and Technologies

While chemistry is closely related to the identification of new active principle, diagnostic and therapeutic strategies in Life Sciences, it is both a pure and an applied science, whose drivers have a significant impact on drug discovery and development.

Read more: With what: Platforms and Technologies

 

Why: Background/Rationale

Equally important than the incubator function performed by CISI scrl is to provide to already existing young companies, often forced to focus their internal investments in a few areas, access to specialized groups of researchers. For example, the opportunity to work in key areas such as modern, high throughput synthetic, computational and analytical chemistry; or access to tangible assets and expertise in therapeutic areas such as infectious diseases and oncology.

The UniMi CISI Center of Excellence in the past, and CISI Scrl now, developed their internal skills, Platforms and Technologies so to support young and dynamic Italian companies in the above mentioned areas. This should limit the investment needed for young companies to access an integrated R&D engine, but should also create a fertile ground to stimulate people and groups with original ideas in Biotech/Life Sciences to develop them properly.

Read more: Why: Background/Rationale